Therapeutic Vaccination Strategies:
The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2000
|
Schriftenreihe: | Ernst Schering Foundation Symposium Proceedings
30 |
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity against the neoplastic cells. Numerous observations and intense research clearly document the major contribution of the immune system to the prevention of cancer. And there are many re ports of patients suffering from malignant melanoma or other tumors who mount a spontaneous immune response against their tumor cells that results in tumor regression. Based on the recent advances in our understanding of the compo nents of our immune system, their interactions and the regulation of immune responses, we are now able to design vaccination strategies that induce or enhance cell-mediated immunity against tumors. A ma jor advancement came with the identification and characterization of relevant tumor antigens, which are suitable target structures for anti-tu mor immune response. First clinical trials using such vaccine strategies have yielded encouraging results in patients. However, in spite of many reported cases of successful therapy of cancer by vaccination many patients still do not experience relief after such treatments. These initial clinical trials and the accompanying investigations have revealed a number of important results that indicate the direction of future re search and development in the field |
Beschreibung: | 1 Online-Ressource (XV, 195 p. 30 illus., 5 illus. in color) |
ISBN: | 9783662041833 |
DOI: | 10.1007/978-3-662-04183-3 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046146570 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2000 |||| o||u| ||||||eng d | ||
020 | |a 9783662041833 |9 978-3-662-04183-3 | ||
024 | 7 | |a 10.1007/978-3-662-04183-3 |2 doi | |
035 | |a (ZDB-2-SME)978-3-662-04183-3 | ||
035 | |a (OCoLC)1119003291 | ||
035 | |a (DE-599)BVBBV046146570 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.5 |2 23 | |
084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
084 | |a XD 3305 |0 (DE-625)152554:12911 |2 rvk | ||
245 | 1 | 0 | |a Therapeutic Vaccination Strategies |c edited by P. Walden, W. Sterry, H. Hennekes |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 2000 | |
300 | |a 1 Online-Ressource (XV, 195 p. 30 illus., 5 illus. in color) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Ernst Schering Foundation Symposium Proceedings |v 30 | |
520 | |a The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity against the neoplastic cells. Numerous observations and intense research clearly document the major contribution of the immune system to the prevention of cancer. And there are many re ports of patients suffering from malignant melanoma or other tumors who mount a spontaneous immune response against their tumor cells that results in tumor regression. Based on the recent advances in our understanding of the compo nents of our immune system, their interactions and the regulation of immune responses, we are now able to design vaccination strategies that induce or enhance cell-mediated immunity against tumors. A ma jor advancement came with the identification and characterization of relevant tumor antigens, which are suitable target structures for anti-tu mor immune response. First clinical trials using such vaccine strategies have yielded encouraging results in patients. However, in spite of many reported cases of successful therapy of cancer by vaccination many patients still do not experience relief after such treatments. These initial clinical trials and the accompanying investigations have revealed a number of important results that indicate the direction of future re search and development in the field | ||
650 | 4 | |a Dermatology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Immunology | |
650 | 4 | |a Pharmacology/Toxicology | |
650 | 4 | |a Molecular Medicine | |
650 | 4 | |a Dermatology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Immunology | |
650 | 4 | |a Toxicology | |
650 | 4 | |a Medicine | |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gentherapie |0 (DE-588)4296957-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Impfung |0 (DE-588)4026656-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Berlin |2 gnd-content | |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 1 | 1 | |a Gentherapie |0 (DE-588)4296957-8 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 2 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Impfung |0 (DE-588)4026656-4 |D s |
689 | 3 | |5 DE-604 | |
700 | 1 | |a Walden, P. |4 edt | |
700 | 1 | |a Sterry, W. |4 edt | |
700 | 1 | |a Hennekes, H. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662041857 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662041840 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540672982 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-662-04183-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526755 | ||
966 | e | |u https://doi.org/10.1007/978-3-662-04183-3 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484720164864 |
---|---|
any_adam_object | |
author2 | Walden, P. Sterry, W. Hennekes, H. |
author2_role | edt edt edt |
author2_variant | p w pw w s ws h h hh |
author_facet | Walden, P. Sterry, W. Hennekes, H. |
building | Verbundindex |
bvnumber | BV046146570 |
classification_rvk | XD 3300 XD 3305 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-662-04183-3 (OCoLC)1119003291 (DE-599)BVBBV046146570 |
dewey-full | 616.5 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.5 |
dewey-search | 616.5 |
dewey-sort | 3616.5 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-662-04183-3 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04305nmm a2200769zcb4500</leader><controlfield tag="001">BV046146570</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783662041833</subfield><subfield code="9">978-3-662-04183-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-662-04183-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-662-04183-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119003291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146570</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.5</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3305</subfield><subfield code="0">(DE-625)152554:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic Vaccination Strategies</subfield><subfield code="c">edited by P. Walden, W. Sterry, H. Hennekes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XV, 195 p. 30 illus., 5 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ernst Schering Foundation Symposium Proceedings</subfield><subfield code="v">30</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity against the neoplastic cells. Numerous observations and intense research clearly document the major contribution of the immune system to the prevention of cancer. And there are many re ports of patients suffering from malignant melanoma or other tumors who mount a spontaneous immune response against their tumor cells that results in tumor regression. Based on the recent advances in our understanding of the compo nents of our immune system, their interactions and the regulation of immune responses, we are now able to design vaccination strategies that induce or enhance cell-mediated immunity against tumors. A ma jor advancement came with the identification and characterization of relevant tumor antigens, which are suitable target structures for anti-tu mor immune response. First clinical trials using such vaccine strategies have yielded encouraging results in patients. However, in spite of many reported cases of successful therapy of cancer by vaccination many patients still do not experience relief after such treatments. These initial clinical trials and the accompanying investigations have revealed a number of important results that indicate the direction of future re search and development in the field</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dermatology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dermatology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Berlin</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Gentherapie</subfield><subfield code="0">(DE-588)4296957-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walden, P.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sterry, W.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hennekes, H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662041857</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662041840</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540672982</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-662-04183-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526755</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-662-04183-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1999 Berlin gnd-content |
genre_facet | Konferenzschrift 1999 Berlin |
id | DE-604.BV046146570 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:30Z |
institution | BVB |
isbn | 9783662041833 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526755 |
oclc_num | 1119003291 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XV, 195 p. 30 illus., 5 illus. in color) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
series2 | Ernst Schering Foundation Symposium Proceedings |
spelling | Therapeutic Vaccination Strategies edited by P. Walden, W. Sterry, H. Hennekes Berlin, Heidelberg Springer Berlin Heidelberg 2000 1 Online-Ressource (XV, 195 p. 30 illus., 5 illus. in color) txt rdacontent c rdamedia cr rdacarrier Ernst Schering Foundation Symposium Proceedings 30 The induction of immune responses against tumor cells by vaccination is rapidly evolving as a therapeutic modality with new potentials for the treatment of cancer. It is based on the fact that our immune system can identify tumor cells and, once activated, is capable of developing specific immunity against the neoplastic cells. Numerous observations and intense research clearly document the major contribution of the immune system to the prevention of cancer. And there are many re ports of patients suffering from malignant melanoma or other tumors who mount a spontaneous immune response against their tumor cells that results in tumor regression. Based on the recent advances in our understanding of the compo nents of our immune system, their interactions and the regulation of immune responses, we are now able to design vaccination strategies that induce or enhance cell-mediated immunity against tumors. A ma jor advancement came with the identification and characterization of relevant tumor antigens, which are suitable target structures for anti-tu mor immune response. First clinical trials using such vaccine strategies have yielded encouraging results in patients. However, in spite of many reported cases of successful therapy of cancer by vaccination many patients still do not experience relief after such treatments. These initial clinical trials and the accompanying investigations have revealed a number of important results that indicate the direction of future re search and development in the field Dermatology Oncology Immunology Pharmacology/Toxicology Molecular Medicine Oncology Toxicology Medicine Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Immuntherapie (DE-588)4026640-0 gnd rswk-swf Gentherapie (DE-588)4296957-8 gnd rswk-swf Impfung (DE-588)4026656-4 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1999 Berlin gnd-content Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s DE-604 Gentherapie (DE-588)4296957-8 s Impfstoff (DE-588)4026655-2 s Impfung (DE-588)4026656-4 s Walden, P. edt Sterry, W. edt Hennekes, H. edt Erscheint auch als Druck-Ausgabe 9783662041857 Erscheint auch als Druck-Ausgabe 9783662041840 Erscheint auch als Druck-Ausgabe 9783540672982 https://doi.org/10.1007/978-3-662-04183-3 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Therapeutic Vaccination Strategies Dermatology Oncology Immunology Pharmacology/Toxicology Molecular Medicine Oncology Toxicology Medicine Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd Gentherapie (DE-588)4296957-8 gnd Impfung (DE-588)4026656-4 gnd Impfstoff (DE-588)4026655-2 gnd |
subject_GND | (DE-588)4073781-0 (DE-588)4026640-0 (DE-588)4296957-8 (DE-588)4026656-4 (DE-588)4026655-2 (DE-588)1071861417 |
title | Therapeutic Vaccination Strategies |
title_auth | Therapeutic Vaccination Strategies |
title_exact_search | Therapeutic Vaccination Strategies |
title_full | Therapeutic Vaccination Strategies edited by P. Walden, W. Sterry, H. Hennekes |
title_fullStr | Therapeutic Vaccination Strategies edited by P. Walden, W. Sterry, H. Hennekes |
title_full_unstemmed | Therapeutic Vaccination Strategies edited by P. Walden, W. Sterry, H. Hennekes |
title_short | Therapeutic Vaccination Strategies |
title_sort | therapeutic vaccination strategies |
topic | Dermatology Oncology Immunology Pharmacology/Toxicology Molecular Medicine Oncology Toxicology Medicine Krebs Medizin (DE-588)4073781-0 gnd Immuntherapie (DE-588)4026640-0 gnd Gentherapie (DE-588)4296957-8 gnd Impfung (DE-588)4026656-4 gnd Impfstoff (DE-588)4026655-2 gnd |
topic_facet | Dermatology Oncology Immunology Pharmacology/Toxicology Molecular Medicine Oncology Toxicology Medicine Krebs Medizin Immuntherapie Gentherapie Impfung Impfstoff Konferenzschrift 1999 Berlin |
url | https://doi.org/10.1007/978-3-662-04183-3 |
work_keys_str_mv | AT waldenp therapeuticvaccinationstrategies AT sterryw therapeuticvaccinationstrategies AT hennekesh therapeuticvaccinationstrategies |